Capstone Holding CORP. (CAPS) — SEC Filings

Overview

Capstone Holding CORP. (CAPS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 16, 2026: On April 16, 2026, Capstone Holding Corp. filed an 8-K report detailing a voluntary adjustment to its conversion price. This adjustment is related to a material definitive agreement, as indicated by Item 1.01 and Exhibit 10.1 of the filing.

Sentiment Summary

Across 26 filings, the sentiment breakdown is: 2 bearish, 22 neutral, 2 mixed. The dominant filing sentiment for Capstone Holding CORP. is neutral.

Filing Type Overview

Capstone Holding CORP. (CAPS) has filed 15 8-K, 3 10-Q, 3 S-1, 1 DEF 14A, 3 S-1/A, 1 10-K with the SEC between Dec 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (26)

• Capstone Holding Corp. Adjusts Conversion Price — 8-K · Apr 16, 2026 Risk: medium
  On April 16, 2026, Capstone Holding Corp. filed an 8-K report detailing a voluntary adjustment to its conversion price. This adjustment is related to a material
• Capstone Holding Corp. Files 8-K for Material Agreement and Officer Changes — 8-K · Dec 29, 2025 Risk: medium
  On December 19, 2025, Capstone Holding Corp. entered into a material definitive agreement. The company also reported the departure of directors or certain offic
• 8-K Filing — 8-K · Dec 15, 2025
• Capstone Holding Corp. Reports Material Definitive Agreement & Acquisition — 8-K · Dec 2, 2025 Risk: medium
  On November 30, 2025, Capstone Holding Corp. entered into a material definitive agreement related to the completion of an acquisition or disposition of assets.
• Capstone Holding Corp. Files 8-K: Material Agreement & Exhibits — 8-K · Nov 28, 2025 Risk: medium
  On November 28, 2025, Capstone Holding Corp. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial stat
• 8-K Filing — 8-K · Nov 24, 2025
• Capstone's Q3 Loss Widens Amid Restructuring and Acquisition Costs — 10-Q · Nov 18, 2025 Risk: high
  Capstone Holding Corp. (CAPS) reported a net loss of $2.014 million for the three months ended September 30, 2025, a significant increase from the $0.998 millio
• 8-K Filing — 8-K · Nov 17, 2025
• 8-K Filing — 8-K · Nov 7, 2025
• Capstone S-1 Signals Resale of 4.3M Shares; No New Capital Raised — S-1 · Oct 23, 2025 Risk: medium
  Capstone Holding Corp. (CAPS) filed an S-1 on October 23, 2025, for the resale of 4,306,664 shares of common stock by a selling stockholder, convertible from a
• Capstone Holding Corp. Files 8-K with Key Corporate Updates — 8-K · Oct 6, 2025 Risk: medium
  On September 30, 2025, Capstone Holding Corp. filed an 8-K report detailing several significant events. These include entering into a material definitive agreem
• Capstone Proposes Nevada Re-domicile, New Stock Plan at Annual Meeting — DEF 14A · Oct 1, 2025 Risk: medium
  Capstone Holding Corp. (CAPS) is holding its Annual Meeting on November 18, 2025, to address several critical proposals impacting its corporate structure and go
• Capstone Holding Corp. Files Material Definitive Agreement — 8-K · Aug 18, 2025 Risk: medium
  On August 15, 2025, Capstone Holding Corp. filed an 8-K report detailing a material definitive agreement. The filing also included financial statements and exhi
• Capstone Holding Corp. Files Q2 2025 10-Q Report — 10-Q · Aug 15, 2025 Risk: low
  Capstone Holding Corp. filed its quarterly report for the period ended June 30, 2025. The company, formerly known as Capstone Therapeutics Corp. and Orthologic
• Capstone Holding Corp. Files 8-K: Material Agreement & Financial Obligation — 8-K · Aug 4, 2025 Risk: medium
  On July 29, 2025, Capstone Holding Corp. entered into a material definitive agreement, which also created a direct financial obligation for the company. The fil
• Capstone Holding Corp. Files 8-K — 8-K · Jun 30, 2025 Risk: low
  Capstone Holding Corp. filed an 8-K on June 30, 2025, reporting on other events and financial statements. The company, formerly known as Capstone Therapeutics C
• Capstone Holding Corp. Signs Material Definitive Agreement — 8-K · Jun 27, 2025 Risk: medium
  On June 26, 2025, Capstone Holding Corp. entered into a Material Definitive Agreement. The filing also includes financial statements and exhibits related to thi
• Capstone Amends S-1 for Continuous Offering, Remains Small Filer — S-1/A · Jun 9, 2025 Risk: high
  Capstone Holding Corp. (CAPS) filed an S-1/A on June 9, 2025, as an amendment to its initial S-1 registration statement, indicating a proposed sale of securitie
• Capstone Files S-1 for Public Offering, Signals Market Debut — S-1 · Jun 3, 2025 Risk: medium
  Capstone Holding Corp. (CAPS) filed an S-1 registration statement on June 3, 2025, for a proposed public offering of securities. The company, classified under S
• Capstone Holding Corp. Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: low
  Capstone Holding Corp. filed its 10-Q for the quarterly period ended March 31, 2025. The company, formerly known as Capstone Therapeutics Corp. and Orthologic C
• Capstone Holding Corp. Files 8-K — 8-K · Apr 1, 2025 Risk: low
  On April 1, 2025, Capstone Holding Corp. filed an 8-K report. The filing indicates the company's principal executive offices are located at 5141 W. 122nd Street
• Capstone Holding Corp. Files 2024 Annual Report — 10-K · Mar 31, 2025 Risk: low
  Capstone Holding Corp. filed its annual 10-K report for the fiscal year ended December 31, 2024. The company, formerly known as Capstone Therapeutics Corp. and
• Capstone Holding Corp. Files 8-K for Material Agreement — 8-K · Mar 11, 2025 Risk: medium
  On March 5, 2025, Capstone Holding Corp. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statemen
• Capstone Holding Corp. Files S-1/A Amendment — S-1/A · Feb 6, 2025 Risk: medium
  Capstone Holding Corp. filed an S-1/A amendment on February 6, 2025, for its registration statement (No. 333-284105). The company, formerly known as Capstone Th
• Capstone Holding Corp. Files S-1/A Amendment — S-1/A · Jan 27, 2025 Risk: medium
  Capstone Holding Corp. filed an S-1/A amendment on January 27, 2025, for its registration statement. The company, previously known as Capstone Therapeutics Corp
• Capstone Holding Corp. Files S-1 Registration — S-1 · Dec 31, 2024 Risk: medium
  Capstone Holding Corp. filed an S-1 registration statement with the SEC on December 31, 2024. The company, formerly known as Capstone Therapeutics Corp. and Ort

Risk Profile

Risk Assessment: Of CAPS's 22 recent filings, 2 were flagged as high-risk, 15 as medium-risk, and 5 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Capstone Holding CORP.'s most recent 10-Q filing (Nov 18, 2025):

• Revenue: $34,405,000
• Net Income: -$5,147,000
• EPS: -$0.62
• Debt-to-Equity: 1.15
• Cash Position: $730,000
• Operating Margin: -7.13%
• Total Assets: $58,483,000
• Total Debt: $17,255,000

Key Executives

• Matthew Lipman
• Michael Toporek
• Edward Schultz
• Matthew E. Lipman
• Joseph M. Lucosky
• Lawrence Metelitsa
• Steven A. Lipstein

Industry Context

Capstone Holding Corp. operates in the building materials distribution and installation sector, serving residential and commercial construction. This industry is cyclical and sensitive to economic conditions, interest rates, and housing market trends. Competition includes both large national distributors and smaller regional players. The trend towards end-to-end services, as seen with the Carolina Stone acquisition, suggests a move towards greater value-added offerings.

Top Tags

material-agreement (8) · 10-Q (3) · filing (2) · financial-obligation (2) · corporate-actions (2) · Public Offering (2) · S-1 Filing (2) · corporate-action (2) · financials (2) · 8-K (2)

Key Numbers

• Commission File Number: 001-33560 — SEC filing identifier for Capstone Holding Corp.
• I.R.S. Employer Identification No.: 86-0585310 — Tax identification number for Capstone Holding Corp.
• Net Sales (Q3 2025): $13.654M — Increased from $12.318M in Q3 2024
• Net Loss (Q3 2025): $2.014M — Widened from $0.998M in Q3 2024
• Net Loss (9 months 2025): $5.147M — Widened from $4.360M in 9 months 2024
• Cash (Sept 30, 2025): $730K — Increased significantly from $11K at Dec 31, 2024
• Net proceeds from Public Offering: $3.252M — Generated on March 7, 2025
• Goodwill (Sept 30, 2025): $26.030M — Increased from $23.286M at Dec 31, 2024, due to acquisition
• Loss on extinguishment of debt: $652K — Incurred during the nine months ended Sept 30, 2025
• Transaction expenses: $652K — Incurred during the nine months ended Sept 30, 2025
• Common shares outstanding: 8,306,205 — As of November 14, 2025, significantly increased from 157,610 at Dec 31, 2024
• Negative working capital: $907K — As of September 30, 2025 ($19.113M current assets vs $20.020M current liabilities)
• Shares of Common Stock: 4,306,664 — Number of shares offered for resale by the selling stockholder
• Convertible Note Principal: $3,545,712.42 — Amount of the convertible note issued July 29, 2025
• Conversion Price: $1.10 — Fixed price per share for converting the note into common stock

Related Companies

CPST

Frequently Asked Questions